Cargando…
Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism
INTRODUCTION: Osteosarcoma is a malignant tumor associated with high mortality rates due to the toxic side effects of current therapeutic methods. Tanshinone IIA can inhibit cell proliferation and promote apoptosis in vitro, but the exact mechanism is still unknown. The aims of this study are to exp...
Autores principales: | Hu, Chao, Zhu, Xiaobin, Zhang, Taogen, Deng, Zhouming, Xie, Yuanlong, Yan, Feifei, Cai, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376467/ https://www.ncbi.nlm.nih.gov/pubmed/34422073 http://dx.doi.org/10.1155/2021/5563691 |
Ejemplares similares
-
The Prognostic Significance of Src and p-Src Expression in Patients with Osteosarcoma
por: Hu, Chao, et al.
Publicado: (2015) -
MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
por: Xie, Yuanlong, et al.
Publicado: (2017) -
Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
por: Wei, Yingjie, et al.
Publicado: (2012) -
Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
por: Li, Ming, et al.
Publicado: (2021) -
Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis
por: Zhou, Jin, et al.
Publicado: (2020)